[1] Seregni E, Coli A, Mazzucca N, et al. Circulating tumor markers in breast cancer[J]. Eur J Nucl Med Mol Imaging, 2004, 31(Suppl1):S15-S22.
[2] Calvert PM, Frucht H. The genetics of colorectal cancer[J]. Ann Intern Med, 2002, 137(7):603-612.
[3] Lawicki S, Mroczko B, Szmitkowski M. Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms[J]. Postepy Hig Med Dosw, 2002, 56(5):617-634.
[4] Ishizuka D, Shirai Y, Sakai Y, et al. Colorectal carcinoma liver metastases:clinical significance of preoperative measurement of serum carcinoembryonic antigen and carbohydrate antigen 19-9levels[J]. Int J Colorectal Dis, 2001,16(1):32-37.
[5] Carpelan-Holmstrom M, Louhimo J, Stenman UH, et al. Estimating the probability of cancer with several tumor markers in patients with colorectal disease[J]. Oncology, 2004, 66(4):296-302.
[6] Pontieri-Lewis V. Colorectal cancer:prevention and screening[J].Medsurg Nurs, 2000, 9(1):9-13.
[7] 黄萍.大肠癌相关基因改变的研究进展[J].国外医学卫生学分册,2003,30(1):44-48.
[8] Srivastava S, Verma M, Henson DE. Biomarkers for early detection of colon cancer[J]. Clin Cancer Res, 2001, 7(5):1118-1126.
[9] Saito M, Yamaguchi A, Goi T, et al. Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis[J]. Oncology, 1999, 56(2):134-141.
[10] Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome:genetics and clinical implications[J]. Ann Intern Med, 2003, 138(7):560-570.
[11] Tatsumoto N, Hiyama E, Murakami Y, et al. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer[J]. Clin Cancer Res, 2000, 6(7):2696-2701.